Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Alternate Health

DB:2AN
Snowflake Description

Weak fundamentals or lack of information.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
2AN
DB
CA$14M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. The last earnings update was 146 days ago. More info.


Add to Portfolio Compare Print
  • Alternate Health has significant price volatility in the past 3 months.
2AN Share Price and Events
7 Day Returns
-23.9%
DB:2AN
10.8%
DE Healthcare Services
4.3%
DE Market
1 Year Returns
-74.3%
DB:2AN
14.2%
DE Healthcare Services
-14.2%
DE Market
2AN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Alternate Health (2AN) -23.9% 26.5% 45.9% -74.3% - -
DE Healthcare Services 10.8% 3% -3.8% 14.2% 47.1% 117.7%
DE Market 4.3% -9% -21.6% -14.2% -19.6% -25.6%
1 Year Return vs Industry and Market
  • 2AN underperformed the Healthcare Services industry which returned 14.2% over the past year.
  • 2AN underperformed the Market in Germany which returned -14.2% over the past year.
Price Volatility
2AN
Industry
5yr Volatility vs Market

Value

 Is Alternate Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Alternate Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Alternate Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Alternate Health. This is due to cash flow or dividend data being unavailable. The share price is €0.0715.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Alternate Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Alternate Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:2AN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in CAD CA$-0.24
CNSX:AHG Share Price ** CNSX (2020-04-07) in CAD CA$0.13
Germany Healthcare Services Industry PE Ratio Median Figure of 6 Publicly-Listed Healthcare Services Companies 11.55x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 17.07x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Alternate Health.

DB:2AN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:AHG Share Price ÷ EPS (both in CAD)

= 0.13 ÷ -0.24

-0.53x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alternate Health is loss making, we can't compare its value to the DE Healthcare Services industry average.
  • Alternate Health is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Alternate Health's expected growth come at a high price?
Raw Data
DB:2AN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.53x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Europe Healthcare Services Industry PEG Ratio Median Figure of 14 Publicly-Listed Healthcare Services Companies 2.67x
Germany Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.24x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Alternate Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Alternate Health's assets?
Raw Data
DB:2AN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in CAD CA$0.00
CNSX:AHG Share Price * CNSX (2020-04-07) in CAD CA$0.13
Germany Healthcare Services Industry PB Ratio Median Figure of 7 Publicly-Listed Healthcare Services Companies 2.86x
Germany Market PB Ratio Median Figure of 573 Publicly-Listed Companies 1.47x
DB:2AN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:AHG Share Price ÷ Book Value per Share (both in CAD)

= 0.13 ÷ 0.00

-52.13x

* Primary Listing of Alternate Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alternate Health has negative assets, we can't compare the value of its assets to the DE Healthcare Services industry average.

Next steps:

  1. Take a look at our analysis of 2AN’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Alternate Health's regulatory filings and announcements.
  3. Show me more potentially undervalued companies in the Healthcare Services industry
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Alternate Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. Alternate Health has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Alternate Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alternate Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
26.9%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Alternate Health expected to grow at an attractive rate?
  • Unable to compare Alternate Health's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Alternate Health's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Alternate Health's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:2AN Future Growth Rates Data Sources
Data Point Source Value (per year)
Europe Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 26.9%
Europe Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.1%
Germany Market Revenue Growth Rate Market Cap Weighted Average 3.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:2AN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:2AN Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
DB:2AN Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-09-30 4 -6 -18
2019-06-30 2 -7 -21
2019-03-31 0 -10 -23
2018-12-31 1 -12 -24
2018-09-30 1 -11 -26
2018-06-30 2 -11 -26
2018-03-31 9 -10 -27
2017-12-31 13 -7 -26
2017-09-30 13 -4 -13
2017-06-30 12 -3 -10
2017-03-31 4 -1 -4
2016-12-31 0 -1 -2

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Alternate Health is high growth as no earnings estimate data is available.
  • Unable to determine if Alternate Health is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:2AN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Alternate Health Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2AN Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
DB:2AN Past Financials Data
Date (Data in CAD Millions) EPS *
2019-09-30 -0.24
2019-06-30 -0.31
2019-03-31 -0.40
2018-12-31 -0.44
2018-09-30 -0.49
2018-06-30 -0.49
2018-03-31 -0.53
2017-12-31 -0.53
2017-09-30 -0.29
2017-06-30 -0.24
2017-03-31 -0.12
2016-12-31 -0.07

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Alternate Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of 2AN’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Alternate Health's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. Alternate Health's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Alternate Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Alternate Health has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Alternate Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Alternate Health's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Alternate Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Alternate Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Alternate Health's 1-year growth to the DE Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
Alternate Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Alternate Health Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:2AN Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 4.43 -17.74 9.57 0.48
2019-06-30 1.84 -21.16 11.69 0.48
2019-03-31 0.42 -23.19 15.76 0.48
2018-12-31 0.58 -23.99 16.43 0.48
2018-09-30 1.20 -25.66 17.04 -0.13
2018-06-30 2.38 -25.50 17.52 0.02
2018-03-31 9.12 -26.70 21.15 0.26
2017-12-31 13.25 -26.13 26.76 0.51
2017-09-30 13.29 -13.33 23.68 0.58
2017-06-30 11.65 -9.62 19.78 0.48
2017-03-31 4.45 -4.48 10.06 0.25
2016-12-31 0.18 -2.05 1.73
2016-09-30 0.18 -0.50 0.48 0.05
2015-12-31 0.17 -0.23 0.29
2014-12-31 0.01 -0.54 0.42 0.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Alternate Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Alternate Health has efficiently used its assets last year compared to the DE Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Alternate Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Alternate Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Alternate Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Alternate Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Alternate Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Alternate Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Alternate Health's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Alternate Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Alternate Health has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Alternate Health Company Filings, last reported 6 months ago.

DB:2AN Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 -0.19 3.30 2.81
2019-06-30 -3.09 3.41 2.01
2019-03-31 -1.04 3.27 1.84
2018-12-31 1.07 3.13 3.90
2018-09-30 6.01 2.60 0.49
2018-06-30 9.60 1.36 0.30
2018-03-31 15.77 0.57 0.50
2017-12-31 16.11 0.55 1.44
2017-09-30 24.93 0.54 3.89
2017-06-30 26.42 0.52 5.73
2017-03-31 26.49 0.51 11.03
2016-12-31 1.31 0.54 0.57
2016-09-30 1.30 0.52 0.91
2015-12-31 0.26 0.47 0.43
2014-12-31 0.04 0.48
  • Alternate Health has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Alternate Health's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Alternate Health has less than a year of cash runway based on current free cash flow.
  • Alternate Health has less than a year of cash runway if free cash flow continues to grow at historical rates of 45.4% each year.
X
Financial health checks
We assess Alternate Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Alternate Health has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Alternate Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Alternate Health dividends.
If you bought €2,000 of Alternate Health shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Alternate Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Alternate Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:2AN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 314 Stocks 3.6%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.6%
Germany Top 25% Dividend Yield 75th Percentile 4.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:2AN Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Alternate Health has not reported any payouts.
  • Unable to verify if Alternate Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Alternate Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Alternate Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Alternate Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Alternate Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Alternate Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Alternate Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Howard Mann
COMPENSATION CA$40,695
TENURE AS CEO 1.3 years
CEO Bio

Mr. Howard W. Mann has been the Chief Executive Officer and Director of Alternate Health Corp. since December 11, 2018. He founded Alternate Health Corp. in 2014 and was instrumental in its growth and public listing at the beginning of 2017. He served as Chief Executive Officer and President of Alternate Health Corp. since April 16, 2015 until May 13, 2015. Mr. Mann has founded numerous businesses and consulted on various membership platforms, online advertising and marketing platforms, streaming media and cloud storage platforms, social networking, television and video production, animation production, merchandising, branding, and direct marketing projects. He has direct experience with international licensing, as well as creating numerous domestic and international commercial programs, merchandising items, and electronic rights properties. He has been an Member of Advisory Board of New Global Energy, Inc. (NGEY) since January 05, 2015. He serves as a Director of Alternate Health Inc., and VIP LLC.

CEO Compensation
  • Insufficient data for Howard to compare compensation growth.
  • Howard's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the Alternate Health management team in years:

1.3
Average Tenure
  • The average tenure for the Alternate Health management team is less than 2 years, this suggests a new team.
Management Team

Howard Mann

TITLE
Founder
COMPENSATION
CA$41K
TENURE
1.3 yrs

Chris Boling

TITLE
Chief Financial Officer
COMPENSATION
CA$214K
TENURE
2.3 yrs

Jay Briggs

TITLE
Senior Vice President of Operations
COMPENSATION
CA$203K
TENURE
1.3 yrs

Robert Blaine

TITLE
President
TENURE
0.8 yrs

Stephen Bugbee

TITLE
Senior Vice President of Technology
TENURE
1.5 yrs
Board of Directors Tenure

Average tenure of the Alternate Health board of directors in years:

1.3
Average Tenure
  • The average tenure for the Alternate Health board of directors is less than 3 years, this suggests a new board.
Board of Directors

Howard Mann

TITLE
Founder
COMPENSATION
CA$41K
TENURE
1.3 yrs

Robert Blaine

TITLE
President
TENURE
0.8 yrs

Jim Tykoliz

TITLE
Independent Director
COMPENSATION
CA$32K
AGE
62
TENURE
5 yrs

Kyle Kemper

TITLE
Director
TENURE
1.3 yrs

Leigh Valentine

TITLE
Director
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
17. Oct 19 Buy James Tykoliz Individual 10. Oct 19 10. Oct 19 23,500 €0.14 €3,214
03. Oct 19 Sell James Tykoliz Individual 27. Sep 19 27. Sep 19 -150,000 €0.14 €-20,773
19. Sep 19 Sell Alpha Blue Ocean Advisors Ltd Company 09. Sep 19 10. Sep 19 -113,000 €0.10 €-11,732
10. Sep 19 Sell Alpha Blue Ocean Advisors Ltd Company 12. Jul 19 06. Sep 19 -847,493 €0.20 €-103,535
01. Aug 19 Buy Robert Chidgey Individual 30. Jul 19 30. Jul 19 400 €0.16 €65
X
Management checks
We assess Alternate Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Alternate Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Alternate Health Corp., a diversified healthcare company, provides cloud based software solutions in Canada. It offers medical practice and controlled substance management software, blood analysis and toxicology labs, clinical research, continuing education programs, nutraceutical products, and security and control services to the medical cannabis industry. The company is headquartered in Toronto, Canada.

Details
Name: Alternate Health Corp.
2AN
Exchange: DB
Founded:
CA$9,017,004
105,696,706
Website: http://www.alternatehealth.com
Address: Alternate Health Corp.
99 Yorkville Avenue,
Suite 200,
Toronto,
Ontario, M5R 3K5,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX AHG Common Shares Canadian National Stock Exchange CA CAD 24. Jan 2017
OTCPK AHGI.F Common Shares Pink Sheets LLC US USD 24. Jan 2017
DB 2AN Common Shares Deutsche Boerse AG DE EUR 24. Jan 2017
Number of employees
Current staff
Staff numbers
0
Alternate Health employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 05:52
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2018/04/30
Last earnings filing: 2019/11/14
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.